InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: asmarterwookie post# 185084

Saturday, 08/02/2014 4:42:20 PM

Saturday, August 02, 2014 4:42:20 PM

Post# of 345706
H. Choe's profile was just updated since June 2014.... and can be re-inforced with this latest publication:

page 4 of 6 of the link below (yes, Barton Haynes is included just above H. Choe's publication)

Journal of Virology - JVI

AUGUST 2014 • VOLUME 88 • NO. 16

SPOTLIGHT

Articles of Significant Interest Selected from This Issue by the
Editors

VIRUS-CELL INTERACTIONS


Human and Host Species Transferrin Receptor 1 Use by North
American Arenaviruses


Min Zong, Isabel Fofana, Hyeryun
Choe


http://jvi.asm.org/content/88/16.toc.pdf



-------------------------------------------

will list the sources below from back in June.... and again, this all stems from Choe publicly backing PS Targeting (March 27, 2014) when state stated "This is where the trouble begins..." when PS flips to the outside of the cellular membrane. She seems to be raising the alarm "arms race" on these viruses below.

------------------------------------------

Human and host species transferrin receptor 1 use by north american arenaviruses.

Zong M 1,
Fofana I 1,
Choe H2.

Author information

1Department of Infectious Diseases, The Scripps Research Institute, Jupiter, Florida, USA.
2Department of Infectious Diseases, The Scripps Research Institute, Jupiter, Florida, USA hchoe@scripps.edu.

Abstract

At least five New World (NW) arenaviruses cause hemorrhagic fevers in South America. These pathogenic clade B viruses, as well as nonpathogenic arenaviruses of the same clade, use transferrin receptor 1 (TfR1) of their host species to enter cells. Pathogenic viruses are distinguished from closely related nonpathogenic ones by their additional ability to utilize human TfR1 (hTfR1). Here, we investigate the receptor usage of North American arenaviruses, whose entry proteins share greatest similarity with those of the clade B viruses. We show that all six North American arenaviruses investigated utilize host species TfR1 orthologs and present evidence consistent with arenavirus-mediated selection pressure on the TfR1 of the North American arenavirus host species. Notably, one of these viruses, AV96010151, closely related to the prototype Whitewater Arroyo virus (WWAV), entered cells using hTfR1, consistent with a role for a WWAV-like virus in three fatal human infections whose causative agent has not been identified. In addition, modest changes were sufficient to convert hTfR1 into a functional receptor for most of these viruses, suggesting that a minor alteration in virus entry protein may allow these viruses to use hTfR1. Our data establish TfR1 as a cellular receptor for North American arenaviruses, highlight an "arms race" between these viruses and their host species, support the association of North American arenavirus with fatal human infections, and suggest that these viruses have a higher potential to emerge and cause human diseases than has previously been appreciated.
IMPORTANCE:

hTfR1 use is a key determinant for a NW arenavirus to cause hemorrhagic fevers in humans. All known pathogenic NW arenaviruses are transmitted in South America by their host rodents. North American arenaviruses are generally considered nonpathogenic, but some of these viruses have been tentatively implicated in human fatalities. We show that these North American arenaviruses use the TfR1 orthologs of their rodent host species and identify TfR1 polymorphisms suggesting an ongoing "arms race" between these viruses and their hosts. We also show that a close relative of a North American arenavirus suggested to have caused human fatalities, the Whitewater Arroyo species complex virus AV96010151, uses human TfR1. Moreover, we present data that imply that modest changes in other North American arenaviruses might allow these viruses to infect humans. Collectively, our data suggest that North American arenaviruses have a higher potential to cause human disease than previously assumed.

Copyright © 2014, American Society for Microbiology. All Rights Reserved.

PMID:
24920811
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/24920811



-------------------------------------------------------







"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News